Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Motzer, Robert J.; Penkov, Konstantin; Haanen, John; Rini, Brian; Albiges, Laurence; Campbell, Matthew T.; Venugopal, Balaji; Kollmannsberger, Christian; Negrier, Sylvie; Uemura, Motohide; Lee, Jae L.; Vasiliev, Aleksandr; Miller, Wilson H., Jr.; Gurney, Howard; Schmidinger, Manuela; Larkin, James; Atkins, Michael B.; Bedke, Jens; Alekseev, Boris; Wang, Jing; Mariani, Mariangela; Robbins, Paul B.; Chudnovsky, Aleksander; Fowst, Camilla; Hariharan, Subramanian; Huang, Bo; di Pietro, Alessandra; Choueiri, Toni K.

Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma

Autor(en):

Motzer, Robert J.; Penkov, Konstantin; Haanen, John; Rini, Brian; Albiges, Laurence; Campbell, Matthew T.; Venugopal, Balaji; Kollmannsberger, Christian; Negrier, Sylvie; Uemura, Motohide; Lee, Jae L.; Vasiliev, Aleksandr; Miller, Wilson H., Jr.; Gurney, Howard; Schmidinger, Manuela; Larkin, James; Atkins, Michael B.; Bedke, Jens; Alekseev, Boris; Wang, Jing; Mariani, Mariangela; Robbins, Paul B.; Chudnovsky, Aleksander; Fowst, Camilla; Hariharan, Subramanian; Huang, Bo; di Pietro, Alessandra; Choueiri, Toni K.

Tübinger Autor(en):

Bedke, Jens

Erschienen in:

New England Journal of Medicine (2019), Bd. 380, H. 12, S. 1103-1115

Verlagsangabe:

Massachusetts Medical Soc

Sprache:

Englisch

Referenz zum Volltext:

http://dx.doi.org/10.1056/NEJMoa1816047

ISSN:

1533-4406